Home › Entities › monoclonal_antibody › imdevimab

imdevimab

monoclonal antibody against SARS-CoV-2 developed by Regeneron
Protein monoclonal_antibody Q99329757

Facts

5 properties
Instance of
monoclonal antibody
Part of
casirivimab/imdevimab[3]
Developer
Regeneron Pharmaceuticals[2]
Imported from
wholeness_audit_2026-05-02
Name
REGN10987[4]
🏷️ Also known as
en imdevimab en REGN 10987 en REGN-10987 en REGN10987 ja イムデヴィマブ ja イムデビマブ uk Імдевімаб
🔖 Identifiers · 5
CAS Registry Number
2415933-40-1
DrugBank ID
DB15940
Google Knowledge Graph ID
/g/11qnt9jzdx
RxNorm CUI
2465249
UNII
2Z3DQD2JHM

Report an error or request removal Lineage (PROV-JSON)

Press Enter · cited answer in seconds

Summary

imdevimab is a monoclonal antibody[1].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). imdevimab. Retrieved November 3, 2026, from https://4ort.xyz/entity/imdevimab
MLA “imdevimab.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 Nov. 2026, https://4ort.xyz/entity/imdevimab.
BibTeX @misc{4ortxyz_imdevimab_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{imdevimab}}, year = {2026}, url = {https://4ort.xyz/entity/imdevimab}, note = {Accessed: 2026-11-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): imdevimab — https://4ort.xyz/entity/imdevimab (retrieved 2026-11-03)

Canonical URL: https://4ort.xyz/entity/imdevimab · Last refreshed: